These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32628952)

  • 21. Comparison between the efficacy of intralesional rituximab versus intralesional triamcinolone in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial.
    Iraji F; Danesh F; Faghihi G; Siadat A; Mokhtari F; Talakoob M; Hafezi H
    Int Immunopharmacol; 2019 Aug; 73():94-97. PubMed ID: 31082727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
    Ojaimi S; O'Connor K; Lin MW; Schifter M; Fulcher DA
    Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy.
    Cho YT; Huang YM; Wang LF; Chu CY
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):230-237. PubMed ID: 31103376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S; Platamone A; Alaimo R; Bongiorno MR
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive therapy for autoimmune bullous diseases.
    Meurer M
    Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
    Ahmed AR; Spigelman Z; Cavacini LA; Posner MR
    N Engl J Med; 2006 Oct; 355(17):1772-9. PubMed ID: 17065638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.
    Beissert S; Mimouni D; Kanwar AJ; Solomons N; Kalia V; Anhalt GJ
    J Invest Dermatol; 2010 Aug; 130(8):2041-8. PubMed ID: 20410913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
    Thiel J; Salzer U; Hässler F; Effelsberg NM; Hentze C; Sic H; Bartsch M; Miehle N; Peter HH; Warnatz K; Schlesier M; Voll RE; Venhoff N
    Autoimmunity; 2013 Nov; 46(7):429-38. PubMed ID: 23742274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the Effects of Rituximab Monotherapy on Different Subsets of Circulating T-Regulatory Cells and Clinical Disease Severity in Severe Pemphigus Vulgaris.
    Bhattacharjee R; De D; Handa S; Minz RW; Saikia B; Joshi N
    Dermatology; 2016; 232(5):572-577. PubMed ID: 27576321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
    Dastgheib L; Sadati MS; Baghernejhad M
    J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents].
    Michałowski R; Kuczyńska L
    Przegl Dermatol; 1981; 68(2):227-32. PubMed ID: 7029660
    [No Abstract]   [Full Text] [Related]  

  • 34. IL-10-producing regulatory B cells are decreased in patients with psoriasis.
    Hayashi M; Yanaba K; Umezawa Y; Yoshihara Y; Kikuchi S; Ishiuji Y; Saeki H; Nakagawa H
    J Dermatol Sci; 2016 Feb; 81(2):93-100. PubMed ID: 26614745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
    Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
    Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pemphigus: current therapy.
    Rosenkrantz WS
    Vet Dermatol; 2004 Apr; 15(2):90-8. PubMed ID: 15030557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    Werth VP; Joly P; Mimouni D; Maverakis E; Caux F; Lehane P; Gearhart L; Kapre A; Pordeli P; Chen DM;
    N Engl J Med; 2021 Jun; 384(24):2295-2305. PubMed ID: 34097368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.
    Gopaluni S; Smith RM; Lewin M; McAlear CA; Mynard K; Jones RB; Specks U; Merkel PA; Jayne DR;
    Trials; 2017 Mar; 18(1):112. PubMed ID: 28270229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.